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CLINICAL AND PSYCHIATRIC MANIFESTATIONS OF BURNING MOUTH SYNDROME
KLINIČKE I PSIHIJATRIJSKE MANIFESTACIJE SINDROMA PEČENJA USTA
Milija Mijajlović1, Jasna Zidverc-Trajković1, Dragan Stanimirović2, Ljiljana Janković2, Nadežda Šternić1
Abstract: According to International Headache Society (IHS) classifi cation, burning mouth syndrome 
(BMS) is intra oral burning sensation without obvious medical and dental cause. IHS diagnostic criteria 
of the disorder include the presence of burning oral sensation during the most period of day without obvi-
ous changes of oral mucosa. Local and systemic causes have to be excluded by appropriate diagnostic pro-
cedures. Subjective feeling of dry mouth, paraesthesia and taste changes could be associated symptoms. Es-
timated prevalence of BMS in general population varies between 1 and 15% and the disorder is seven times 
more common in females.
Th is condition is probably of multifactorial origin, oft en idiopathic, and its etiology and pathogenesis has 
not been elucidated completely yet. More recently, increasing attention has been given to the altered percep-
tion of sensory functions as well as to the changes in the psychological profi le of many BMS patients. As a 
result, both disturbances should be included in the clinical spectrum of BMS.
BMS represents a disorder with a poor prognosis in terms of quality of life and treatment possibili-
ties. As a result, BMS subjects continue to be high consumers of healthcare resources.As in the oth-
er chronic pain conditions it has been reported that depression and anxiety are strongly associat-
ed with BMS and that they are signifi cantly more frequent in BMS patients than in non-BMS subjects.
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Sažetak: Prema međunarodnoj klasifi kaciji glavobolja Internacionalnog društva za glavobolje (Interna-
tional Headache Society-IHS), sindrom pečenja usta (burning mouth syndrome-BMS) predstavlja osećaj 
pečenja u usnoj duplji, a bez očiglednog medicinskog ili stomatološkog uzroka. IHS dijagnostički kriteriju-
mi za ovaj poremećaj uključuju prisustvo senzacije pečenja u usnoj duplji za vreme najvećeg perioda dana, 
bez vidlivih promena sluznice usne duplje. Lokalni i sistemski uzroci moraju biti isključeni primenom 
odgovarajućih dijagnostičkih procedura. Subjektivni osećaj suvoće usta, parestezija i izmena osećaja uku-
sa mogu biti udruženi simptomi.
Procenjena prevalenca BMS u opštoj populaciji varira izmedju 1 i 15%, a poremećaj je sedam puta češći 
kod žena. Ovaj poremećaj je verovatno multifaktorijelnog porekla, često idiopatski, a njegova etiologija i 
patogeneza nisu u potpunosti razjašnjeni.  U skorašnjim studijama, posebno se ističe značaj izmenjene 
percepcije senzornih funkcija i sistema kao i specifi čna promena psihološkog profi la mnogih pacijenata sa 
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BMS. Zbog toga se preporučuje da oba navedena poremećaja budu uključena u klinički raznovrstan spek-
tar BMS. BMS ima lošu prognozu u pogledu kvaliteta života obolelih i terapijskih mogućnosti, a kao re-
zultat ovaj poremećaj predstavlja veliki socio-ekonomski i medicinski problem. Kao i kod drugih hroničnih 
bolnih stanja, postoji značajna udruženost BMS sa depresijom i anksioznošću. Ovi ali i drugi psihijatrijski 
i psihološki poremećaji su značajno češći kod pacijenata sa BMS u odnosu na zdravu populaciju.
Ključne reči: sindrom pečenja usta, klasifi kacija, klinička prezentacija, psihijatrijske manifestacije
INTRODUCTION
According to the International Classifi cation of 
Headache Disorders (IHC), burning mouth syn-
drome (BMS) is an intraoral burning sensation for 
which no medical or dental cause can be found 
(1). BMS, coded 13.18.5, is classifi ed in IHC as a 
separate group with other cranial neuralgias and 
central causes of facial pain (1).
Diagnostic criteria include: (1)
Pain in the mouth present daily and per-A. 
sisting for most of the day
Oral mucosa is of normal appearanceB. 
Local and systemic diseases have been ex-C. 
cluded
* Pain may be confi ned to the tongue (glosso-
dynia).
* Subjective dryness of the mouth, paraesthesia 
and altered taste may be associated symptoms.
Epidemiological studies have estimated BMS to be 
prevalent in 1–15% of the general population and 
it is a disorder which is seven times more com-
mon in females than males (2). Despite the large 
number of clinical and epidemiological studies, 
pathogenesis and aetiology of BMS remains un-
clear (3). Recent clinical, electrophysiological (4, 
5) and histological (6) studies suggest that primary 
neuropathic dysfunction might be involved in the 
pathogenesis of BMS. On the other hand, a central 
mechanism with the involvement of dopamine re-
ceptors in the basal ganglia was suggested to play 
a role in the pathogenesis of the disease (7).Re-
cently, we published the data which showed based 
on decreased calcitonin gene-related peptide lev-
els in saliva of BMS patients that trigeminal nerve 
degeneration may be the underlying cause of BMS 
(8).
Psychological factors are, however, frequently as-
sociated with BMS. Previous studies have shown 
diagnoses such as depression, generalized anxiety, 
hypochondriasis, and cancer phobia are oft en rep-
resented in patients with BMS (9).
It has been reported that depression and anxiety 
are strongly associated with BMS and that they are 
more frequent in BMS patients than in non-BMS 
subjects (10-13). In contrast to this correlation, 
some authors assert that higher levels of anxiety 
and depression can be the consequence of chronic 
pain of BMS (14).
Th is chronic pain syndrome mainly aff ects mid-
dle-aged women with hormonal changes or psy-
chological disorders. BMS is probably of multifac-
torial origin, oft en idiopathic, and its etiopatho-
genesis remains largely obscure. BMS represents 
a disorder with a very poor prognosis in terms of 
quality of life, and the patient’s lifestyle may wors-
en when psychological dysfunctions occur (15). 
Despite the fact that a voluminous amount has 
been published in this fi eld, a universally accepted 
defi nition of this syndrome is still lacking. Various 
synonyms—such as stomatopyrosis, glossopyro-
sis, stomatodynia, glossodynia, sore mouth, sore 
tongue, and oral dysesthesia—have been adopt-
ed to emphasize the quality and/or the location of 
pain in the oral cavity. In this syndrome, however, 
pain represents the main symptom within a variety 
of chronic oral complaints. Th us, BMS appears to 
be the most appropriate terminology. Despite this 
large body of evidence, some issues on BMS are 
still debated, and they present a challenge for both 
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researchers and clinicians. What generates a ma-
jor dilemma is that BMS is defi ned by symptoms 
that can potentially arise from numerous diff er-
ent local/systemic pathologies, some of which can 
be clearly identifi ed and managed, and others that 
elude diagnosis and, thus, hamper management 
(15). Several authors (16, 17) have focused their ef-
forts on establishing whether BMS should be con-
sidered as a distinct “syndrome”, or if it mostly rep-
resents a “symptom disruption” for a large number 
of conditions arising from a wide array of pathol-
ogies (hormonal changes, nutritional defi cien-
cy, etc.). Th ey have proposed the lack of local/sys-
temic factors as inclusion criteria for a “true BMS”, 
and assumed that all the other types of “unremit-
ting oral burning” correlated to diff erent patholo-
gies may be one symptom within the clinical spec-
trum of such a group of pathologies. Burning pain 
without mucosal or skin lesions, however, repre-
sents the typical symptom of chronic neuropath-
ic pain conditions resulting from nerve damage, 
and in recent years a neuropathic basis of BMS 
has been better identifi ed through the use of more 
sensitive diagnostic techniques (18). Th is new ev-
idence, in increasingly larger groups of BMS sub-
jects, suggests a common background of neuropa-
thy in the pathogenesis of this syndrome. As a re-
sult, it seems more appropriate to recognize two 
clinical forms of BMS: “Primary BMS”, or essen-
tial/idiopathic BMS for which organic local/sys-
temic causes cannot be identifi ed; and “Secondary 
BMS”, resulting from local/systemic pathological 
conditions and thus potentially sensitive to etiol-
ogy-directed therapy. According to these criteria, 
“idiopathic” BMS as well as the “secondary” form 
may represent two distinctive subgroups of the 
same “pathological entity”(15-18).
Classifi cation of the BMS types and subtypes
According to potential associated etiologies, BMS 
may be divided into primary and secondary types. 
Primary type includes idiopathic, non-neuropath-
ic BMS. Burning mouth sensations (formerly, sec-
ondary BMS) are associated with established or-
ganic/therapeutic-related etiologies (e.g., oral cav-
ity disorders, including oral local neuropathy, sys-
temic disorders, nutritional defi ciencies, drug-in-
duced, neurological and psychiatric abnormali-
ties) (19).
Burning mouth sensations are symptoms of these 
alterations and according to available literature, 
do not represent a distinct type of BMS. Th e latter 
starts with a diff erential diagnosis based on the ex-
clusion of both other orofacial chronic pain condi-
tions and painful oral diseases exhibiting mucos-
al lesions. Th e cooccurrence of overlapping/over-
whelming oral mucosal pathologies, such as infec-
tions, may cause diffi  culties in the diagnosis and it 
is classifi ed as “complicated BMS” (19).
Burning mouth syndrome has been further divid-
ed into three subtypes based on the daily varia-
tion of the symptoms (19): Type I BMS refers to 
complaints of burning sensation every day, that is 
not present in the morninig on awakening but de-
velops later during the day, being maximal in the 
evenings. Type 2 BMS (the most frequent subtype; 
relative frequency: 55%) characterized by constant 
burning pain all day, every day. Th e patients with 
Type 2 BMS tend to be most resistant to therapy. 
In type 3 BMS (relative frequency about 10%) pain 
is present intermittently on some days with pain-
free intervals and aff ects unusual sites, such as 
buccal mucosa or the throat. Nonpsychiatric fac-
tors have been linked with Type 1 BMS, psychiat-
ric factors, especially chronic anxiety with Type 2, 
and food additives or fl avoring allergies with Type 
3 BMS (19). 
CLINICAL PRESENTATION
BMS is dominantly characterized by burning and/
or painful sensations of the mouth with no mu-
cosal lesions or any other clinical signs. It can oc-
cur at any site within or surrounding the oral cav-
ity. Th e most frequently aff ected site is the tongue, 
in particular the tip and anterior two thirds, fol-
lowed by the lower lip and hard palate (15, 19). 
Th e pain in BMS is experienced as quantitatively 
similar to, but qualitatively diff erent from tooth-
ache pain. BMS can be considered as a chronic 
pain syndrome with symptoms usually lasting for 
several months to several years (15). Oral burning 
is most prevalent in postmenopausal women; fi g-
ures of up to 40% have been presented. Th e prev-
alence of prolonged oral burning of BMS patients 
is about 8% with less than 1% suff ering from con-
tinuous burning symptoms (15, 18).  Th e term 
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BMS clinically describes a variety of chronic oral 
symptoms (Table 1) that oft en increase in intensi-
ty at the end of each day, and that seldom interfere 
with sleep (15). Accordingly, two specifi c clinical 
features defi ne this syndrome: (1) a “symptom-
atic triad”, which includes unremitting oral mu-
cosal pain, dysgeusia, and xerostomia; and (2) “no 
signs” of lesion(s) or other detectable change(s) in 
the oral mucosa, even in the painful area(s) (15). 
In the remaining cases, “oligosymptomatic” (pain 
and dysgeusia or pain and xerostomia) or “mono-
symptomatic” (pain only) forms of BMS are the 
most frequent presentations. 
More recently, increasing attention has been giv-
en to the altered perception of sensory/chemosen-
sory functions as well as to the changes in the psy-
chological profi le of many BMS patients. As a re-
sult, both disturbances should be included in the 
clinical spectrum of BMS (18). Oral pain repre-
sents the cardinal symptom of BMS. Th e type of 
pain experienced by BMS patients is a prolonged 
“burning” sensation of the oral mucosa. Howev-
er, scalding, tingling, or numb feelings of the oral 
mucosa have also been reported (15-19). Th e on-
set of oral pain is generally spontaneous and with-
out any recognizable precipitating factors. Some 
individuals with BMS relate the onset of pain to 
previous events such as dental procedures (par-
ticularly dental extractions, dental prostheses) or 
other disease (15).
PSYCHIATRIC MANIFESTATIONS
Personality and mood changes (especially anxiety 
and depression) have been consistently demon-
strated in patients with burning mouth syndrome 
and have been used to suggest that the disorder 
is a psychogenic problem. However, psychologic 
dysfunction is common in patients with chronic 
pain and may be the result of the pain rather than 
its cause.
Table 1. Main symptoms in patients with BMS.
Symptom Type(s) of Complaint(s)
Oral mucosal pain* (main complaint)
Burning
Scalding
Tingling
Numb feeling
Dysgeusia* Altered taste perception
Xerostomia* Dry mouth
Others
Th irst
Headache
TMJ pain
Tenderness/pain in masticatory muscles, 
neck, shoulder, and suprahyoid muscles
  * BMS symptomatic triad; TMJ = temporomandibular joint.
Concerning the association between BMS and 
psychiatric diseases, an extensive literature, vary-
ing from anecdotal reports, psychoanalytic opin-
ions, and controlled comparisons to large-scale 
surveys, attests to the importance that is gener-
ally assigned to the relationship between psychi-
atric disorders and BMS. Despite diff erent meth-
odological approaches and sometimes small study 
groups, all of the studies reported a high preva-
lence of psychiatric symptoms or of mental disor-
ders: About 50% of the cases of BMS are comor-
bid with other current psychiatric disorders (20). 
Th ere has been particular emphasis on depression 
(21), chronic anxiety (22), cancerophobia, and hy-
pochondriasis (20)
Th e association of psychiatric disorders, funda-
mentally depression and anxiety, with BMS has 
oft en been reported in the literature. As a result, 
some authors have suggested a psychosocial cause 
for BMS (20, 23). 
Although there is widespread agreement over the 
participation of psychosocial aspects in the cause 
of this disorder, current thought is that multiple 
factors are involved (20-23).
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However, when reviewing the literature, it is in-
teresting to note that anxiety and depression are 
the two psychopathologic factors in BMS that 
have almost exclusively been evaluated by ques-
tionnaires. Th e situation of these patients in oth-
er psychopathologic contexts is somewhat uncer-
tain, although recently a number of studies have 
addressed the subject (20).
Van de Ploeg et al reported on the high frequen-
cy of somatic reactions to stress observed in a se-
ries of 154 patients with BMS. Th e preoccupation 
of these patients with their physical condition and 
bodily functions constitutes a further feature of 
BMS with hypochondriac reactions (24). 
In the study of Lamey and Lamb (25) the major-
ity of the 75 patients studied were female, which 
agrees with previous studies relating to burning 
mouth syndrome. Analysis of the Hospital Anxi-
ety and Depression (HAD) scale completed by the 
patients in this study showed that 39% had clin-
ically signifi cant anxiety, 23% had anxiety scores 
of borderline signifi cance and 38% were not anx-
ious. 
Th e depression subscale presented very diff erent 
score ranges, with 13% indicated as having depres-
sion, and 68% having scores that corresponded to 
a non-depressive state. 19% had results of border-
line signifi cance (25).
From the results of this study it could be conclud-
ed that more than one third of the BMS patients, 
the majority of whom were female, had anxiety. 
Th is suggested that their somatic symptoms of 
burning mouth were at least partly the psycholog-
ical result of restlessness, tension, and an inherent 
inability to relax (25). Only one in seven patients 
in this cohort had depression, suggesting that de-
pression does not seem to play an important role 
in the etiology of burning mouth syndrome as 
previous publications suggested (25).
Th e fi ndings in the study of Rojo et al. (22) sug-
gested that from the psychiatric and psychopatho-
logic viewpoint two groups of patients with BMS 
may be distinguished: those with associated psy-
chiatric symptoms and those without these symp-
toms. No psychopathologic phenomenon was de-
tected that was common to all patients with BMS 
and that diff erentiated them from controls free of 
oral symptoms. Th e association of BMS and psy-
chological changes might be a mere coincidence, 
although the high percentage of persons with 
BMS who have these alterations (about 50%) com-
pared with the general population would seem to 
disprove this. 
BMS patients may be particularly vulnerable to 
psychiatric problems, primarily depression and 
anxiety. Such comorbidity could be mediated by 
many factors, including those of psychological na-
ture, particularly in persons suff ering chronic pain 
condition or other psychological triggering fac-
tors (20-22).
Consideration should also be given to other possi-
ble explanations for the association between BMS 
and depression or anxiety disorders, including the 
possibility that both aspects might be the product 
of a common factor. 
In this sense, Wardrop et al. (26) for the fi rst time 
more than 20 years ago suggested that the observed 
higher incidence of these alterations among post-
menopausal women points to an endocrine disor-
der as the underlying cause of both the oral and 
psychopathologic symptoms.
Th e most commonly observed association is be-
tween BMS and depressive and anxiety symptoms. 
Th e items on the anxiety and depression scales 
tend to exhibit marked correlations to the point 
of rendering it empirically impossible to develop 
independent subscales of these two psychopatho-
logic entities (21, 22).
TREATMENT
Th e treatment of BMS is usually directed at its 
symptoms and is the same as the medical manage-
ment of other neuropathic pain conditions (27). 
Studies generally support the use of low dosages of 
clonazepam (28), chlordiazepoxide (29) and tricy-
clic antidepressants (30). 
Evidence also supports the utility of a low dosage 
of gabapentin (31). 
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Studies have not shown any benefi t from treat-
ment with selective serotonin reuptake inhibitors 
or other serotoninergic antidepressants (27).
Although benzodiazepines might exert their eff ect 
on oral burning by acting as a sedative-hypnotic, 
this possibility appears to be unlikely because the 
maximal eff ect of clonazepam is usually observed 
at lower dosages (27).
Th e benefi cial eff ects of tricyclic antidepressants in 
decreasing chronic pain indicate that, in low dos-
ages, these agents may act as analgesics (27, 30).
Topical capsaicin has been used as a desensitizing 
agent in patients with burning mouth syndrome. 
However, capsaicin may not be palatable or useful 
in many patients (32).
CONCLUSION
BMS is the disorder with high prevalence in gen-
eral population and is much more common in fe-
males and older age. Although many factors were 
described to be associated with BMS, etiopatho-
genesis has not been completely understood yet. 
Recent studies suggested that either primary neu-
ropathic dysfunction or central mechanism with 
the involvement of dopamine receptors in the 
basal ganglia were suggested to play a role in the 
pathogenesis of the disease. BMS represents a dis-
order with a very poor prognosis in terms of qual-
ity of life, and the patient’s lifestyle worsens when 
psychological dysfunctions occur.
Th e hallmark of this pain condition is a triad of 
intraoral burning and/or painful sensation, dys-
geusia and xerostomia which is very frequently as-
sociated with personality and mood changes such 
as anxiety and depression. 
Besides the primary BMS, there are plenty of med-
ical and dental disoders, as well as drugs that could 
cause secondary BMS. Th ese symptomatic causes 
have to be excluded particularly in older patients.
Treatment of BMS is challenging. It is usually di-
rected at its symptoms and is the same as the med-
ical management of other neuropathic pain con-
ditions
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